ASCO 2020：11项中国分析入选口头报告，17项Poster报告

所受全球新冠疫情影响，原定于5月29日~6月2日在明尼阿波利斯举行的美国外科该协会（ASCO）年会今年将首次以两条路线上形式举办，这是目前最大规模的两条路线上盛会。今天，开会的简述考题公告，共有103个sessions，之前国共有有11项数据分析入选为口头报告，17项入选为Poster

Pyrotinib or lapatinib plus capecitabine for HER2+ metastatic breast cancer (PHOEBE): A randomized phase III trial.Session: Breast Cancer—MetastaticAuthor(s): Binghe Xu, Min Yan, Fei Ma, Xi-Chun Hu, Ji Feng Feng, Quchang Ouyang, Zhongsheng Tong, Huiping Li, Qingyuan Zhang, Tao Sun, Xian Wang, Yongmei Yin, Ying Cheng, Wei Li, Xiaoyu Zhu, Chunxia Chen, Jianjun ZouAbstract: 1003

吡咯替尼或莱切替尼加卡培他鹿岛主要用途HER2+冠心病肝胃癌（PHOEBE）：一项III期随机实验。

演奏会：冠心病肝胃癌

笔记：之前国医学科学院疗养院徐兵河讲师、马飞讲师，上海交通大学另设疗养院胡夕春讲师等

简述号：1003

Phase III trial of metronomic capecitabine maintenance after standard treatment in operable triple-negative breast cancer (SYSUCC-001).

Session: Breast Cancer—Local/Regional/Adjuvant

Author(s): XI Wang, Shu-Sen Wang, Heng Huang, Li Cai, Rou-Jun Peng, Li Zhao, Ying Lin, Jian Zeng, Le-Hong Zhang, Yong-Li Ke, Xian-Ming Wang, Xin-Mei Liu, Qian-Jun Chen, An-Qin Zhang, Dan-Mei Pang, Fei Xu, Jia J. Huang, Yanxia Shi, Jun Tang, Zhongyu Yuan

Abstract: 507

可动手术三阴开放性肝胃癌标准化疗程后卡培他鹿岛维持节拍低剂量的III期实验（SYSUCC-001）。

演奏会：肝胃癌—渐进/区域/特别设计疗程

笔记：松山大学卫生保健教育之前心王树森讲师等

简述号：507

Utilizing phenotypic characteristics of metastatic brain tumors to predict the probability of circulating tumor DNA detection from cerebrospinal fluid.Session: New Tools to Combat Old FoesAuthor(s): Meichen Li, Delan Li, Xue Hou, Xiangheng Zhang, Na Wang, Jianzhong Liang, Jing Chen, Kaicheng Wang, Fufeng Wang, Yedan Chen, Xian Zhang, Hua Bao, Xue Wu, Xiaonan Wang, Yang Shao, Likun ChenAbstract: 2507

利用冠心病神经的遗传基因相似性来得出结论神经脊液之前循环系统DNA检测的标准化差: 新工具抗衡从前劲敌

演奏会：新工具妥善解决从前问题

笔记：李美芹 李菲尔德等

简述号: 2507

Donafenib versus sorafenib as first-line therapy in advanced hepatocellular carcinoma: An open-label, randomized, multicenter phase II/III trial.

Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Author(s): Feng Bi, Shukui Qin, Shanzhi Gu, Yuxian Bai, Zhendong Chen, Zishu Wang, Jieer Ying, Yinying Lu, Zhiqiang Meng, Hongming Pan, Ping Yang, Helong Zhang, Xi Chen, Aibing Xu, Xiufeng Liu, Qiu Meng, Liqing Wu, Feng Chen

Abstract: 4506

多纳非尼对福林拉非尼作为晚期肝细胞核肝癌的一两条路线疗程：一项封闭页面、随机、多教育之前心II/III期实验。

演奏会：食道肠道肝癌—食道食道、胰腺和绝

笔记：四川大学亚东疗养院毕锋讲师、人民解放军二七疗养院秦叔逵讲师等

简述号：4506

Apatinib as second-line therapy in Chinese patients with advanced hepatocellular carcinoma: A randomized, placebo-controlled, double-blind, phase III study.

Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Author(s): Qiu Li, Shukui Qin, Shanzhi Gu, Xiaoming Chen, Lizhu Lin, Zishu Wang, Aibing Xu, Xi Chen, Cuncai Zhou, Zhenggang Ren, Lin Yang, Li Xu, Yuxian Bai, Lei Chen, Jun Li, Hongming Pan, Bangwei Cao, Weijia Fang, Ping Yan, Chunlei Jin

Abstract: 4507

之前国晚期肝病病人阿帕替尼二两条路线疗程：一项随机、安慰剂对照、CPAIII期数据分析

演奏会：食道肠道肝癌—食道食道、胰腺和绝

笔记：人民解放军二七疗养院秦叔逵讲师、四川大学亚东疗养院李秋讲师等

简述号：4507

A randomized phase III trial of secondary cytoreductive surgery in later recurrent ovarian cancer: SOC1/SGOG-OV2.

Session: Gynecologic Cancer

Author(s): Rongyu Zang, Jianqing Zhu, Tingyan Shi, Jihong Liu, Dongsheng Tu, Sheng Yin, Rong Jiang, Ping Zhang, Huixun Jia, Yuting Luan, Yuqin Zhang, Xiaojun Chen, Xiao Huang, Wenjuan Tian, Wen Gao, Yanling Feng, Huijuan Yang, Xi Cheng, Yulang Cai

Abstract: 6001

晚期高血压卵巢肝癌二次细胞核减灭术的一项随机III期实验：SOC1 / SGOG-OV2。

回顾：妇产科肝胃癌

笔记：上海交通大学另设松山疗养院臧荣余讲师等

简述：6001

Sequential chemoradiation versus radiation alone or concurrent chemoradiation in adjuvant treatment after radical hysterectomy for stage IB1-IIA2 cervical cancer (STARS Study): A randomized, controlled, open-label, phase III trial.

Session: Gynecologic Cancer

Author(s): He Huang, Yanling Feng, Ting Wan, Yanna Zhang, Xinping Cao, Yongwen Huang, Ying Xiong, Xin Huang, Min Zheng, Yanfang Li, Jundong Li, Guandi Chen, Hu Li, Yile Chen, Liguo Ma, Hongying Yang, Li Li, Shuzhong Yao, Qing Liu, Jihong Liu

Abstract: 6007

IB1-IIA2期宫颈肝癌根治开放性子宫切除术后特别设计疗程之前的序贯放低剂量对比实质上前列腺肝癌或不间断放低剂量（STARS数据分析）：一项随机、对照、封闭页面的III期实验。

开会：妇产科肝胃癌

笔记：松山大学卫生保健教育之前心黄鹤讲师、刘继红讲师等

简述号：6007

CTONG1104: Adjuvant gefitinib versus chemotherapy for resected N1-N2 NSCLC with EGFR mutation—Final overall survival ysis of the randomized phase III trial 1 ysis of the randomized phase III trial.

Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Author(s): Yi-Long Wu, Wenzhao Zhong, Qun Wang, Weimin Mao, Song-Tao Xu, Lin Wu, Chun Chen, Ying Cheng, Lin Xu, Jun Wang, Xiao-Fei Li, Jian Li, Cheng Huang, Zhidong Liu, Shun Xu, Jin-Ji Yang, Hong-Hong Yan, Xue-Ning Yang, Si-yang Liu, Qing Zhou

Abstract: 9005

CTONG1104：特别设计吉非替尼对比低剂量主要用途可切除的EGFR基因的N1-N2期NSCLC-随机III期外科实验的再次总体适应环境量化。

回顾：膀胱肝癌—非小细胞核渐进-区域/小细胞核/其他面部

笔记：广东省人民疗养院吴一龙讲师等

简述号：9005

First-line tyrosine kinase inhibitor with or without aggressive upfront local radiation therapy in patients with EGFRm oligometastatic non-small cell lung cancer: Interim results of a randomized phase III, open-label clinical trial (SINDAS) (NCT02893332).

Session: Lung Cancer—Non-Small Cell Metastatic

Author(s): Xiaoshan Wang, Ming Zeng

Abstract: 9508

EGFR基因辄转移非小细胞核膀胱肝癌病人一两条路线代谢物激酶抑制剂重新组建或不重新组建尽力前两条路线渐进前列腺肝癌：III期封闭页面外科随机实验（SINDAS）的之前期结果（NCT02893332）。

回顾：膀胱肝癌-非小细胞核转移

笔记：四川省人民疗养院曾铭讲师等

简述：9508

Overall survival and biomarker ysis of a phase Ib combination study of toripalimab, a humanized IgG4 mAb against programmed death-1 (PD-1) with axitinib in patients with metastatic mucosal melanoma.

Session: Melanoma/Skin Cancers

Author(s): Xinan Sheng, Xieqiao Yan, Zhihong Chi, Lu Si, Chuanliang Cui, Bixia Tang, Siming Li, Lili Mao, BIN LIAN, Xuan Wang, Xue Bai, Li Zhou, Yan Kong, Jie Dai, Keith Flaherty, Jun Guo

Abstract: 10007

Toripalimab，一种针对程序开放性死亡-1（PD-1）的人源化IgG4单克隆抗体重新组建阿昔替尼主要用途冠心病黏膜阿兹海默病人的Ib期数据分析的总适应环境期和微生物标志物量化。

回顾：阿兹海默/恶开放性肿刺毛

笔记：上海交通大学疗养院郭军、盛锡楠讲师等

简述：10007

Safety and efficacy results of GC027: The first-in-human, universal CAR-T cell therapy for relapsed/refractory T-cell acute lymphoblastic leukemia (r/r T-ALL).Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Xinxin Wang, Shiqi Li, Lei Gao, Zhongtao Yuan, Kun Wu, Lin Liu, Le Luo, Yao Liu, Cheng Zhang, Jia Liu, Chunhui Yang, Yu Li, Jiaping He, Xun Ye, Zhimin Li, Xu Tan, Jianning Ge, Wei Cao, Sanbin Wang, Xi ZhangAbstract: 3013Poster: 77 GC027的耐用开放性和结果：通用CAR-T细胞核首次药剂实验疗程入院/难治开放性T细胞核急开放性淋巴细胞核白血病（r/r T-ALL）的耐用开放性和。开会：开发计划之前的疗程技术-免疫疗程。笔记：王恰巧等简述：3013名片：77 Sintilimab in patients with advanced esophageal squamous cell carcinoma refractory to previous chemotherapy: A randomized, open-label phase II trial (ORIENT-2).Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Jianming Xu, Yi Li, Qingxia Fan, Yongqian Shu, Zhijun Wu, Tongjian Cui, Kangsheng Gu, Min Tao, Xiuwen Wang, Chengxu Cui, Nong Xu, Juxiang Xiao, Quanli Gao, Yunpeng Liu, Tao Zhang, Hui Zhou, Yan Wang, Linxinyu Xu, Zhuo Ma, Yanqi WangAbstract: 4511Poster: 119 信迪利类类固醇在晚期食道表皮细胞核肝癌病人之前的应用领域：一项随机的封闭页面II期实验（ORIENT-2）。开会：食道肠道肝癌-食道食道肝癌、胰腺肝癌和绝道肝癌笔记：徐建明讲师等简述：4511名片：119 Eradication of medulloblastoma by NKG2D-specific CAR T-cells.Session: Central Nervous System TumorsAuthor(s): Hong-jiu Dai, Bin Sun, Dong Yang, Hui Xu, Jingjing Zhu, Jia Wei, Xudong ZhaoAbstract: 2522Poster: 13 NKG2D特异开放性CAR-T细胞核对肾母细胞核刺毛的根除开放性疗程开会：之前枢神经系统笔记：代红久、孙斌、杨东、徐晖、杨晶晶、魏佳、赵旭东简述：2522名片。13 Envafolimab (KN035) in advanced tumors with mismatch-repair deficiency.Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Lin Shen, Jian Li, Yanhong Deng, Weijie Zhang, Aiping Zhou, Weijian Guo, Jianwei Yang, Ying Yuan, Liangjun Zhu, Shukui Qin, Silong Xiang, Haolan Lu, John Gong, Ting Xu, Did LiuAbstract: 3021Poster: 85 Envafolimab（KN035）在晚期错配修复缺陷病人之前的应用领域开会：开发计划之前的疗程学-免疫疗程笔记：沈琳讲师等简述：3021名片。85 First-in-human clinical trial of the autologous CD7-CART for relapsed/refractory ACUTE lymphoblastic leukemia/lymphoma.Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Mingzhi Zhang, Lin Yang, Xiaorui Fu, Lei Zhang, Huimin Meng, Ling Li, Xin Li, Xinhua Wang, Zhenchang Sun, Hui Yu, Zhaoming Li, Feifei Nan, Yu Chang, Zhiyuan Zhou, Jiaqin Yan, Jiwei Li, Min Wang, Fengtao You, Yu-Sheng Chen, Bozhen ZhangAbstract: 3026Poster: 90 自体CD7-CART疗程入院/难治开放性ACUTE淋巴细胞核白血病/白血病的首例药剂外科实验开会: 开发计划开放性疗程学-免疫疗程笔记简介：张明志，杨林等简述：3026名片: 90 A phase Ib study of simmitecan (LP) single-agent and in combination with 5-fluorouracil/leucovorin (5-FU/LV) or thalidomide (T) in patients with advanced solid tumor.Session: Developmental Therapeutics—Molecularly Targeted Agents and Tumor BiologyAuthor(s): Jifang Gong, Ting Deng, Jie Li, Ming Lu, Jian Li, Yi Ba, Qiuqiong Yu, Lin ShenAbstract: 3523Poster: 253 罗勒替康（LP）单药和5-氟尿嘧啶/白藜芦醇（5-FU/LV）或沙利度酰（T）重新组建用到晚期实体刺毛病人的Ib期数据分析开会：发展开放性疗程学---分子靶向类固醇和微生物学笔记：龚继芳，沈琳讲师等简述：3523名片：253 A phase II study of rh-endostatin combined with paclitaxel and nedaplatin in treating patients with recurrent or metastatic esophageal squamous cell carcinoma (ESCC).Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Zhiqiang Wang, Yu-Hong Li, De-Shen Wang, Fenghua Wang, Chao Ren, Qiong TanAbstract: 4522Poster: 130 Rh-endostatin重新组建紫杉醇和nedaplatin疗程高血压或冠心病食道表皮细胞核肝癌（ESCC）病人的II期数据分析。开会：食道肠道肝癌-食道食道、胰腺和绝道肝癌的数据分析笔记：王志弱，李玉红，王德申，王凤华，任超，谭琼 王志弱、李玉红、王德深、王凤华、任超、谭琼简述：4522名片：130 HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric adenocarcinoma: A phase II clinical trial.Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Yan Song, Ning Li, Lan Mu, Shu Zhang, Qingxia Fan, Xinjun Liang, Xianli Yin, Zhixiang Zhuang, Yunpeng Liu, Jingdong Zhang, Xiaoge Kou, Haijun Zhong, Jing HuangAbstract: 4524Poster: 132 HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric adenocarcinoma: A phase II clinical trial.开会：食道肠道肝癌-食道食道肝癌、胰腺肝癌和绝管肝癌的二两条路线疗程笔记：宋艳等简述：4524名片：132 A urine exosomal circRNA classifier for detection of high-grade prostate cancer at initial biopsy: A multicenter, retrospective study.Session: Genitourinary Cancer—Prostate, Testicular, and PenileAuthor(s): Liaoyuan Li, Wen Tao, Yadi He, Tao He, Qing Li, Zhenquan Wu, Weiming Deng, Lingxiao ZhangAbstract: 5522Poster: 103 一种尿液外体外侧RNA决策树主要用途初始活检时检测高等级肝癌的尿液外体外侧RNA决策树：一项多教育之前心的回顾开放性数据分析开会：泌尿生殖系统肝胃癌----肝癌、睾丸肝癌和肝癌笔记简介：Liaoyuan Li等简述：5522名片。103 Adjuvant chemotherapy after concurrent chemoradiation therapy for locally advanced cervical cancer.Session: Gynecologic CancerAuthor(s): Lingna Kou, Tao Zhang, Siyun Peng, Yifei Wang, Mingyang Yuan, Minmin LiAbstract: 6031Poster: 202 渐进晚期宫颈肝癌并发低剂量后的特别设计低剂量开会: 妇产科肝胃癌笔记简介： 李珉珉等简述：6031名片：202 Association between calcitonin and efficacy of anlotinib in medullary thyroid carcinoma: An ysis based on the ALTER01031 trial.Session: Head and Neck CancerAuthor(s): Ming Gao, Yihebali Chi, Pingzhang Tang, Zhengang Xu, Xiangqian Zheng, Dapeng Li, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng, Zhendong Li, Hui Liu, Jianwu Qin, Jingqiang Zhu, Ruochuan ChengAbstract: 6526Poster: 187 降钙素与安罗替尼疗程甲状腺肾开放性肝癌的相关开放性：基于ALTER01031实验的量化。会话：肩部笔记：天津市人民政府疗养院高明讲师简述：6526名片。187 Influence of Eastern Cooperative Oncology Group performance status (ECOG PS), tumor size and age on patient outcomes after anlotinib treatment: A subgroup ysis based on ALTER01031 trial for medullary thyroid carcinoma (MTC).Session: Head and Neck CancerAuthor(s): Ming Gao, Yihebali Chi, Xiangqian Zheng, Dapeng Li, Pingzhang Tang, Zhengang Xu, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng, Zhendong Li, Hui Liu, Jianwu Qin, Jingqiang Zhu, Ruochuan ChengAbstract: 6527Poster: 188 ECOG PS、形状和年龄对安洛替尼疗程后病人故事情节的影响: ALTER01031的亚组量化开会：肩部笔记：天津市人民政府疗养院高明讲师简述：6527名片。188 Circulating tumor DNA (ctDNA) ysis predicts recurrence following surgery in patients with stage I-IIIA non-small-cell lung cancer (NSCLC): Results of GASTO1035 and GASTO1018.Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic CancersAuthor(s): Si-Yu Wang, Ning Li, Wei Ou, Chao Cheng, Peng-Peng Kuang, Hui-Qi WuAbstract: 9023Poster: 216 ctDNA量化得出结论I-IIIA期非小细胞核膀胱肝癌（NSCLC）病人术后入院: GASTO1035和GASTO1018的结果开会：膀胱肝癌-非小细胞核渐进-地方开放性/小细胞核/小细胞核/其他胸科肝胃癌笔记：Si-Yu Wang等简述：9023名片：216 Exon-16-skipping ERBB2 (ERBB2ΔEx16) as a novel resistance mechanism against EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC).Session: Lung Cancer—Non-Small Cell MetastaticAuthor(s): Xin Zhao, Linling Jin, Man Yu, Qiuxiang Ou, Hua Bao, Xue Wu, Yang Shao, Min FanAbstract: 9528Poster: 294 ERBB2ΔEx16作为非小细胞核膀胱肝癌（NSCLC）之前EGFR代谢物激酶抑制剂的新型抗药性选择开放性开会:膀胱肝癌-非小细胞核冠心病膀胱肝癌笔记简介：赵昕，金艾利，满宇，欧春花，湛，薛武，杨少，范敏 赵昕、金艾利、满宇、欧春花、湛、薛武、杨绍、范敏简述：9528名片：294 Surrogate endpoints for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials of advanced melanoma.Session: Melanoma/Skin CancersAuthor(s): Run-Cong Nie, Shu-Qiang Yuan, Yuanfang Li, Yingbo Chen, Zhiwei ZhouAbstract: 10030Poster: 379 PD-1/PD-L1实验之前晚期阿兹海默总适应环境的替代终点开会：阿兹海默/恶开放性肿刺毛笔记：聂润聪，袁书弱，李元芳，陈英波，周志伟 聂润聪、袁书弱、李元芳、陈英波、周志伟简述：10030名片：379 A phase II study of anlotinib in treating patients with relapsed or metastatic primary malignant bone tumor.Session: SarcomaAuthor(s): Lina Tang, Xiaohui Niu, Zhen Wang, Qiqing Cai, Chongqi Tu, Zhengfu Fan, Yang YaoAbstract: 11525Poster: 413 安罗替尼疗程入院或冠心病原发开放性恶开放性穿孔病人的II期数据分析开会： 白血病笔记：唐丽娜，牛晓辉，王震，蔡启清，涂崇奇，范正福，杨瑶 唐丽娜、牛晓辉、王琼、蔡启庆、涂崇奇、范正福、杨瑶简述：11525名片。413 Preliminary evaluate the safety and efficacy of anlotinib in advanced sarcoma patients in multi-line therapy.Session: SarcomaAuthor(s): Yao Weitao, Jiaqiang Wang, Peng Zhang, Xin Wang, Xinhui Du, Zhichao Tian, Xiaoying NiuAbstract: 11526Poster: 414 初步评价安罗替尼在晚期白血病病人多两条路线疗程之前的耐用开放性和。开会：白血病笔记：姚伟涛，王家弱，张春，王欣，杜新辉，田志浩，牛晓颖 姚伟涛、王家弱、张春、王鑫、杜鑫辉、田志超、牛晓英简述：11526名片：414